Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mark

Showing results (1351-1360 of 1,377) with videos related to

Pageof 138
Sort By:
Nature Metabolism|March 12, 2025
Glycogen drives tumour initiation and progression in lung adenocarcinomaHarrison A Clarke, Tara R Hawkinson, Cameron J Shedlock, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 24, 2018
Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMANicholas M Selby, Peter J Blankestijn, Peter Boor, et al.
American Journal of Nephrology|February 9, 2026
Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) TrialSunil V Badve, Maha Al Ammari, Craig S Anderson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2020
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristicsDavid C Wheeler, Bergur V Stefansson, Mikhail Batiushin, et al.
Nature|July 23, 2013
Genomic evidence for ameiotic evolution in the bdelloid rotifer Adineta vagaJean-François Flot, Boris Hespeels, Xiang Li, et al.
JAMA|June 4, 2026
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical TrialSunil V Badve, Vlado Perkovic, Vivekanand Jha, et al.
Nature Communications|May 31, 2023
Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapyMarjan M Naeini, Felicity Newell, Lauren G Aoude, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 3, 2018
Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association studyMaria P Hernandez-Fuentes, Christopher Franklin, Irene Rebollo-Mesa, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 24, 2016
Renal artery sympathetic denervation: observations from the UK experienceAndrew S P Sharp, Justin E Davies, Melvin D Lobo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 29, 2019
The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant populationCaragh P Stapleton, Andreas Heinzel, Weihua Guan, et al.
Pageof 138

Showing results (1351-1360 of 1,377) with videos related to

Sort By:
Pageof 138
Nature Metabolism|March 12, 2025
Glycogen drives tumour initiation and progression in lung adenocarcinomaHarrison A Clarke, Tara R Hawkinson, Cameron J Shedlock, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 24, 2018
Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMANicholas M Selby, Peter J Blankestijn, Peter Boor, et al.
American Journal of Nephrology|February 9, 2026
Methods Article for a Study Protocol: Study Design and Baseline Characteristics of the Treatment of Cardiovascular Disease with Low Dose Rivaroxaban in Advanced Chronic Kidney Disease (TRACK) TrialSunil V Badve, Maha Al Ammari, Craig S Anderson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 31, 2020
The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristicsDavid C Wheeler, Bergur V Stefansson, Mikhail Batiushin, et al.
Nature|July 23, 2013
Genomic evidence for ameiotic evolution in the bdelloid rotifer Adineta vagaJean-François Flot, Boris Hespeels, Xiang Li, et al.
JAMA|June 4, 2026
Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease: The TRACK Randomized Clinical TrialSunil V Badve, Vlado Perkovic, Vivekanand Jha, et al.
Nature Communications|May 31, 2023
Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapyMarjan M Naeini, Felicity Newell, Lauren G Aoude, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 3, 2018
Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association studyMaria P Hernandez-Fuentes, Christopher Franklin, Irene Rebollo-Mesa, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 24, 2016
Renal artery sympathetic denervation: observations from the UK experienceAndrew S P Sharp, Justin E Davies, Melvin D Lobo, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 29, 2019
The impact of donor and recipient common clinical and genetic variation on estimated glomerular filtration rate in a European renal transplant populationCaragh P Stapleton, Andreas Heinzel, Weihua Guan, et al.
Pageof 138